Clinical Trials Browser

Phase 1/2 × Ketamine × Head & Neck × Clear all

NCT05156060 2024-10-21

Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer

Phase 1/2 Recruiting

Head and Neck Neoplasms